(410 ILCS 416/30)
    Sec. 30. Reimbursement status as undue inducement. Reimbursement of ancillary costs incurred by a subject under the program:
        (1) does not constitute an undue inducement to
    
participate in a clinical trial;
        (2) is not considered coercion or the exertion of
    
undue influence to participate in a clinical trial; and
        (3) shall be deemed to accomplish parity in access to
    
clinical trials and remove barriers to participation in clinical trials for financially burdened subjects.
(Source: P.A. 103-227, eff. 6-30-23.)